- Home
- App Analytics
- AlzDxRx
- AlzDxRx Vs. HCP Studies
AlzDxRx vs HCP Studies Uso e estatísticas
Primary care providers can screen, evaluate and treat behavioral symptoms of Alzheimer’s disease and related dementias from the convenience of their phone in hand, rather than the cumbersome barrier of the electronic health record or computer screen. The San Diego County Alzheimer’s Project Clinical Roundtable, a group of neurologists, psychiatrists, geriatricians and other specialists, developed best practices guidelines based on international evidence to assist primary care physicians deal with the increasing number of patients with cognitive decline.
Highlights:
• 10 Warning Signs
• Algorithm for screening and Red Flag Signs
• Algorithm for comprehensive evaluation
• Algorithm for behavioral management
• Instruments with scoring within the app: Mini-Cog, AD8, PHQ-9, QDRS, IQCODE, MOCA, and SLUMS
• Maintain test scores for future comparisons
• Email test results to yourself to add quickly to electronic health record
- Apple App Store
- Gratuitos
- Médico
Ranking da Loja
- -
HCP Studies™ is a mobile platform that enables patients to engage in their medical conditions via clinical studies, healthcare experience surveys and health programs. Altura has utilized its 18+ years of experience working with patients, health systems and healthcare professionals (HCPs) to provide HCP Studies™ for patient-centered solutions anytime, anywhere. HCPs can support their patients in a quick and simple way.
- Apple App Store
- Gratuitos
- Médico
Ranking da Loja
- -
AlzDxRx versus HCP Studies comparação de classificação
Compare a tendência de classificação de AlzDxRx nos últimos 28 dias versus HCP Studies
Classificação
Nenhum dado disponível
Comparação da classificação de AlzDxRx vs. HCP Studies por país
Compare a tendência de classificação de AlzDxRx nos últimos 28 dias versus HCP Studies
Todas as categorias
Nenhum dado disponível
Médico
Faça comparações com qualquer site com o nosso teste grátis
AlzDxRx VS.
HCP Studies
19ezembro d, 2024